(2020). Goldmann L, Duan R, Kragh T, et al. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): A new option in HIT? Blood Adv. 2019;3(23):4021-4033. Blood Adv.
Styl cytowania Chicago"Goldmann L, Duan R, Kragh T, Et Al. Oral Bruton Tyrosine Kinase Inhibitors Block Activation of the Platelet Fc Receptor CD32a (FcγRIIA): A New Option in HIT? Blood Adv. 2019;3(23):4021-4033." Blood Adv 2020.
Styl cytowania MLA"Goldmann L, Duan R, Kragh T, Et Al. Oral Bruton Tyrosine Kinase Inhibitors Block Activation of the Platelet Fc Receptor CD32a (FcγRIIA): A New Option in HIT? Blood Adv. 2019;3(23):4021-4033." Blood Adv 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..